Source recordFED

Menzies, Richard

Federal grants & contributions· Canadian Institutes of Health Research· FY2016· $7,899,734· QC

Description

Tackling the two greatest obstacles to Tuberculosis elimination: Treatment of latent infection and drug resistant disease.

Amendment chain · 1 entry

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.

$7,899,734$0Original · 2015-07-01 (start date) · total $7,899,734
  • #02015-07-01$7,899,734
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2015-07-01(start date)$7,899,734—Tackling the two greatest obstacles to Tuberculosis elimination: Treatment of latent infection and drug resist…

Related records · 2

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (exact legal name match; no business number on file)

RefDepartment · programCurrent valueFY
236-2024-2025-Q1-00137Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas$4,617,694FY2025
236-2024-2025-Q1-00445Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas$1,154,425FY2025

Cite as: Glassbox record view · Federal grants & contributions · 236-2015-2016-Q2-00730 · retrieved 2026-11-13.